Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hocanalysis of the Engage trial

被引：0
|
作者：
Arthur Leader
Paul Devroey
Han Witjes
Keith Gordon
机构：
[1] University of Ottawa,The Ottawa Fertility Centre, Division of Reproductive Medicine
[2] Universitair Ziekenhuis Brussel,Center for Reproductive Medicine
[3] MSD Oss B.V.,undefined
[4] Oss,undefined
[5] Merck Sharp & Dohme Corp,undefined
来源：
Reproductive Biology and Endocrinology | / 11卷
关键词：
Protocol flexibility; Controlled ovarian stimulation; Corifollitropin alfa; Recombinant follicle stimulating hormone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
    Leader, Arthur
    Devroey, Paul
    Witjes, Han
    Gordon, Keith
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2013, 11
  • [2] Does treatment flexibility affect clinical outcome of either corifollitropin alfa or daily rFSH regimens?
    Hillensjo, T.
    Yeko, T.
    Witjes, H.
    Elbers, J.
    Devroey, P.
    HUMAN REPRODUCTION, 2011, 26 : I303 - I304
  • [3] Dose Selection of Corifollitropin Alfa by Modeling and Simulation in Controlled Ovarian Stimulation
    de Greef, R.
    Zandvliet, A. S.
    de Haan, A. F. J.
    IJzerman-Boon, P. C.
    Marintcheva-Petrova, M.
    Mannaerts, B. M. J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 79 - 87
  • [4] Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for oocyte donors
    Benchabane, M.
    Santulli, P.
    Maignien, C.
    Bourdon, M.
    De Ziegler, D.
    Chapron, C.
    Gayet, V.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 83 - 88
  • [5] Corifollitropin Alfa A Review of its Use in Controlled Ovarian Stimulation for Assisted Reproduction
    Croxtall, Jamie D.
    McKeage, Kate
    BIODRUGS, 2011, 25 (04) : 243 - 254
  • [6] Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art
    de Carvalho, Bruno Ramalho
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (01): : 43 - 48
  • [7] The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
    Seyhan, Ayse
    Ata, Baris
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 : 243 - 255
  • [8] Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation
    Zandvliet, Anthe S.
    Prohn, Marita
    de Greef, Rik
    van Aarle, Frank
    Sisk, Christine McCrary
    Stegmann, Barbara J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (01) : 74 - 82
  • [9] Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation
    Oehninger, S.
    Nelson, S.
    Verweij, P.
    Stegmann, B.
    HUMAN REPRODUCTION, 2013, 28 : 343 - 344
  • [10] CORIFOLLITROPIN ALFA VERSUS DAILY RECOMBINANT FSH TREATMENT FOR CONTROLLED OVARIAN STIMULATION IN POOR RESPONDERS.
    Kim, C. -H.
    Lee, K. -H.
    Park, E.
    Min, J. -Y.
    Ahn, J. -W.
    Kang, B. -M.
    FERTILITY AND STERILITY, 2013, 100 (03) : S265 - S265
12345